Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
6.46
+0.06 (0.94%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $6.72 million as of March 9, 2026. Its market cap has increased by 34.41% in one year.
Market Cap
6.72M
Enterprise Value
-9.88M
1-Year Change
34.41%
Ranking
Category
Stock Price
$6.46
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $131.30M to $6.72M, a decrease of -94.88%. That is a compound annual growth rate of -26.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.00M | -31.82% |
| Dec 31, 2025 | 8.80M | 300.00% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -73.77% |
| Dec 30, 2022 | 12.20M | -66.94% |
| Dec 31, 2021 | 36.90M | -75.47% |
| Dec 31, 2020 | 150.40M | 367.08% |
| Dec 31, 2019 | 32.20M | 2.88% |
| Dec 31, 2018 | 31.30M | -70.02% |
| Dec 29, 2017 | 104.40M | 161.00% |
| Dec 30, 2016 | 40.00M | -69.54% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 6.93M |
| Immuron | 6.88M |
| Moolec Science | 6.79M |
| Creative Medical Technology Holdings | 6.57M |
| Mustang Bio | 6.54M |
| Aptorum Group | 6.51M |
| XTL Biopharmaceuticals | 6.43M |
| Processa Pharmaceuticals | 6.41M |